avapro has been researched along with Cholestasis, Intrahepatic in 2 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Cholestasis, Intrahepatic: Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annicchiarico, BE | 1 |
| Siciliano, M | 1 |
| Hariraj, R | 1 |
| Stoner, E | 1 |
| Jader, S | 1 |
| Preston, DM | 1 |
2 other studies available for avapro and Cholestasis, Intrahepatic
| Article | Year |
|---|---|
Could irbesartan trigger autoimmune cholestatic hepatitis?
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Chemical | 2005 |
Drug points: prolonged cholestasis associated with irbesartan.
Topics: Antihypertensive Agents; Biphenyl Compounds; Cholestasis, Intrahepatic; Female; Humans; Irbesartan; | 2000 |